ADI powers AI data centers with triple-high tech strategy
The development of artificial intelligence (AI) is closely tied to data centers, and the key hardware infrastructure of these centers…
Insights revealed during casual chat between Nvidia CEO Jensen Huang and Blue
At Nvidia’s GTC, robots once again took center stage. The BDX robot “Blue,” inspired by “Star Wars,” made a surprise…
Submarine cables drive global computing power race, AI training
Submarine cables are crucial for global internet traffic, handling over 95% of data transmission. They enhance intercontinental connectivity, lower latency,…
Nvidia addresses AI robot, autonomous driving concerns with safety guardrails
With the collaboration between Nvidia and major US automaker General Motors (GM), AI is poised to take on a robotic…
Apple reportedly seeks Wipro and LMW as India supply chain expands
Apple is reportedly advancing talks with Indian companies like Wipro and Lakshmi Machine Works (LMW) to diversify its supply chain…
Tan’s mission: Return Intel to Grove-era glory days
Intel possesses abundant talent but suffers from inadequate leadership and direction. If newly-appointed CEO Lip-Bu Tan successfully executes Intel’s 1.8nm…
Innodisk expects 2H25 growth to outpace 1H25
Industrial memory module specialist Innodisk has been diligently pursuing order opportunities from Chinese CSPs and network device customers and anticipates…
Japan approves new strategic energy plan aiming for over 40% renewable energy by 2040
The Japanese government has approved the “Seventh Strategic Energy Plan” and “GX 2040 Vision,” which establish a medium- to long-term…
Notable Approvals | Drugs
News about human drug-related approvals
FDA approves first treatment for adults with complement 3 glomerulopathy, a rare kidney disease, to reduce proteinuria
FDA approves first treatment for adults with complement 3 glomerulopathy, a rare kidney disease, to reduce proteinuria